Home › NDC Lookup › Ingredients › Senna Syrup › 81033-0120-50
Senna Syrup 8.8 mg/5mL Syrup — NDC 81033-0120-50 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

Senna Syrup 8.8 mg/5mL Syrup — NDC 81033-120-50 (Billing 81033-0120-50)

by Kesin Pharma Corporation · 50 CUP, UNIT-DOSE in 1 CARTON / 5 mL in 1 CUP, UNIT-DOSE

This is a package of Senna Syrup 8.8 mg/5mL Syrup from Kesin Pharma Corporation, marketed since May 2025 and currently FDA-listed. It is the main listing for this product, which comes in 3 package sizes.

NDC 81033-0120-50
🏷️ FDA NDC (as labeled) 81033-120-50 billing pads the product segment with a zero
This package
Contains5 mL in 1 cup, unit-dose Pack sizes3 compare ↓
Main listing for product 81033-120 · Also comes in: 50 cups 81033-120-54 50 cups 81033-120-55
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 81033-120-50
Product NDC 81033-120
11-digit billing NDC 81033012050
NCPDP billing unit ML — per mL (volume)
RxCUI 702311
UNII 3FYP5M0IJX
Application # M007
SPL Set ID 360fb98d-c6ad-7bcc-e063-6294a90a9453
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2025-05-26
Route ORAL
Dosage form SYRUP
Substance SENNOSIDES

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GCN Seq No 002922
GCN 08660
HICL code 001289
Ingredient (HICL) Sennosides
HIC1 code D
Therapeutic class — broad (HIC1) Biliary System/Gastro-Intestinal System
HIC2 code D6
Therapeutic class — intermediate (HIC2) Drugs Acting Principally On The Colon
HIC3 code D6S
Therapeutic class — specific (HIC3) Laxatives And Cathartics
AHFS code 56:12.00.00
AHFS class Cathartics And Laxatives
FDB label name SENNA 8.8 MG/5 ML SYRUP CUP
FDB brand name Senna
Legend status O — Over-the-counter (OTC) drug or device
Quick answers
  • GSN (GCN sequence number): 002922
  • GCN: 08660
  • HICL (First Databank): 001289
  • AHFS class code: 56:12.00.00
  • RxCUI (RxNorm): 702311
Why two NDCs? The FDA registers this code as 81033-120-50 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 81033-0120-50. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Contact laxatives class.

Drug family (ATC) Contact laxatives
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

Label name SENNA 8.8 MG/5 ML SYRUP CUP Ingredient Sennosides
📖 What it is MedlinePlus · NLM

Senna is used on a short-term basis to treat constipation. It also is used to empty the bowels before surgery and certain medical procedures. Senna is in a class of medications called stimulant laxatives. It works by increasing activity of the intestines to cause a bowel movement.

Read the full MedlinePlus article ↗
📗 Our plain-language guide HelloPharmacist
  • Senna typically produces a bowel movement within 6 to 12 hours. That's why most people take it at bedtime — so it can do its job overnight and you get results in the morning. If no...
  • How long does it take for senna to work?
  • Senna is designed for short-term, occasional use. You should not use it for more than 1 week unless your doctor specifically tells you it's okay. Using laxatives too often or for t...
  • Laxatives like senna can affect how your body absorbs other medications. To be safe, take senna at least 2 hours before or after any other drugs you use. It's always a good idea to...
📖 Read our full Senna guide →

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer mLPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Try another pack size: 50 cups 50 cups
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
81033-0120-50 You're viewing this Main listing 50 CUP, UNIT-DOSE in 1 CARTON / 5 mL in 1 CUP, UNIT-DOSE 2025-05-26 — Active
81033-0120-54 81033-120-54 50 CUP, UNIT-DOSE in 1 CARTON / 10 mL in 1 CUP, UNIT-DOSE 2025-10-20 — Active
81033-0120-55 81033-120-55 50 CUP, UNIT-DOSE in 1 CARTON / 15 mL in 1 CUP, UNIT-DOSE 2025-10-20 — Active

Pack size FAQ

What quantity is in this package?
This package is listed by the FDA — 50 cup, unit-dose in 1 carton / 5 ml in 1 cup, unit-dose.
What NDC number is used to bill for this package of Senna Syrup 8.8 mg/5mL Syrup?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Senna Liquid 8.8 mg/5mL 00536-1266-59 RUGBY 237 ml $0.037 — Availability likely —
Senna 8.8 mg/5mL 39328-0020-08 Patrin 237 ml $0.037 — Availability likely —
Senna Syrup 8.8 mg/5mL 54859-0808-08 Llorens 237 ml $0.037 — Availability likely —
Senna Syrup 8.8 mg/5mL 57237-0301-24 Rising 237 ml $0.037 — Availability likely —
Senna Syrup 8.8 mg/5mL 58657-0518-08 Method 237 ml $0.037 — Availability likely —
Senna 8.8 mg/5mL 82568-0024-08 AARNA 237 ml $0.037 — Availability likely —
Senna 8.8 mg/5mL 00121-4967-40 PAI 10 cups — — FDA listed —
Senna 8.8 mg/5mL 00536-1483-59 Rugby 237 ml — — FDA listed —
Senna 8.8 mg/5mL 00904-7528-94 Major 10 cups — — FDA listed —
OneLAX SENNA 417.12 mg/237mL 17856-1127-01 ATLANTIC 120 syringes — — FDA listed —
OneLAX SENNA 417.12 mg/237mL 17856-8127-02 Atlantic 50 cups — — FDA listed —
Senna UD 8.8 mg/5mL 39328-0120-50 Patrin 10 cups — — FDA listed —
Senna UD 26.4 mg/15mL 39328-0220-50 Patrin 10 cups — — FDA listed —
Senna Syrup 8.8 mg/5mL 48433-0219-40 Safecor 40 cups — — FDA listed —
Senna Syrup 8.8 mg/5mL 50268-0731-24 AVPAK 24 cups — — FDA listed —
Senna Syrup 8.8 mg/5mL 57237-0310-54 Rising 40 cups — — FDA listed —
GeriCare Senna Syrup 8.8 mg/5mL 57896-0472-08 Geri-Care 237 ml — — FDA listed —
Senna 8.8 mg/5mL 60687-0851-77 American 10 cups — — FDA listed —
Senna Syrup 8.8 mg/5mL 63629-9268-01 Bryant 237 ml — — FDA listed —
SENNA Syrup 8.8 mg/5mL 66424-0562-08 SDA 236 ml — — FDA listed —
Senna 417.12 mg/237mL 68094-0049-62 Precision 10 cups — — FDA listed —
Senna 8.8 mg/5mL 69618-0069-58 Reliable 237 ml — — FDA listed —
OneLAX SENNA 417.12 mg/237mL 71399-0027-08 Akron 237 ml — — FDA listed —
Senna Syrup 8.8 mg/5mL 72090-0022-01 Pioneer 237 ml — — FDA listed —
Senna Syrup 8.8 mg/5mL 72162-1672-02 Bryant 237 ml — — FDA listed —
Senna Syrup 8.8 mg/5mL 73564-0812-08 Aldama 1 bottle — — FDA listed —
Senna Syrup 8.8 mg/5mLthis 81033-0120-50 Kesin 50 cups — — FDA listed —
Senna Syrup 8.8 mg/5mL 84415-0021-01 Everpharm 100 cups — — FDA listed —
Senna Liquid 8.8 mg/5mL 84447-0120-01 Belleview 200000 ml — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2025
On the market since
May 2025
📍
2026
Currently FDA-listed
1 year listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

What it looks like

Color brown
FlavorCherry
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerKesin Pharma Corporation
FDA applicationM007 (OTC MONOGRAPH DRUG)
Labeler code81033
First marketedMay 2025
Product typeHuman Otc Drug
Portfolio38 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🆘 Overdosage 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose
🎯 Indications and Usage 14 words ▾

Uses relieves occasional constipation (irregularity) generally produces bowel movement in 6 to 12 hours

⏱️ Dosage and Administration 66 words ▾

Directions shake well before use do not exceed recommended dose Age Starting Dose Maximun Dose adults and children 12 years of age and over 10 mL to 15 mL once a day preferably at bedtime; increase as needed or as recommended by a doctor 15 mL in the morning and 15 mL at bedtime children under 12 years of age ask a doctor ask a doctor

⚠️ Warnings 16 words ▾

Warnings Do not use laxative products for longer than 1 week unless directed by a doctor

🆘 Overdosage 15 words ▾

In case of overdose, get medical help or contact a Poison Control Center right away.

🧪 Active Ingredient 8 words ▾

Active ingredient (per 5 mL) Sennosides 8.8 mg

🧪 Inactive Ingredients 18 words ▾

Inactive ingredients cherry flavor, citric acid, methylparaben, monoammonium glycyrrhizinate, potassium citrate, propylene glycol, propylparaben, purified water, sorbitol, sucralose

🎯 Purpose 2 words ▾

Purpose Laxative

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

About this NDC listing & data coverage

Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available.
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Kesin Pharma Corporation. Listing status can change — the directory data on this page refreshes weekly.
Does this product come in other package sizes?
Yes — the FDA directory lists 2 other package presentations of this same product, including 50 cups (81033-0120-54), 50 cups (81033-0120-55). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
Kesin Pharma Corporation is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 81033-0105-22 · Kesin 81033-0123-16 · Kesin →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.